Greenline Partners’s Eastman Chemical EMN Stock Holding History

Greenline Partners’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$88	–	267
2025 Q1	$88	Buy	+1	New	+$94	﹤0.01%	568

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Greenline Partners's EMN Position: Q2 2025 in Review

Greenline Partners sold out of Eastman Chemical (EMN) in Q2 2025, closing a stake of 1 share — an estimated $88 sold.

Greenline Partners first reported a position in EMN in Q1 2025 and held it in 1 quarter. The position peaked at $88 in Q1 2025. 751 funds tracked by Wall St. Rank hold EMN as of Q2 2025.

Greenline Partners reported no remaining Eastman Chemical position as of Q2 2025 after selling out during the quarter.
Greenline Partners sold 1 Eastman Chemical share in Q2 2025, an estimated $88.
Greenline Partners first reported a position in Eastman Chemical in Q1 2025 and held it in 1 quarter.
Greenline Partners's Eastman Chemical position peaked at $88 in Q1 2025.
751 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2025.

Based on Greenline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.